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Introduction
Circulating platelet counts and thrombopoietic processes in 
BM megakaryocytes (MKs) are both tightly regulated. In vitro, 
thrombopoiesis occurs via proplatelet formation (PPF) in the 
presence of thrombopoietin (TPO), which entails microtubule-
dependent extension of elongated pseudopodal structures that 
exhibit platelet-sized swellings arranged in tandem and contain-
ing platelet organelles (Patel et al., 2005; Thon et al., 2010; 
Machlus et al., 2014). In vivo studies using two-photon micro-
scopy also confirmed the presence of PPF in mouse BM (Junt 
et al., 2007; Zhang et al., 2012). However, the estimated platelet 
number released from each MK cannot explain rapid platelet 
turnover, especially when the need is acute, such as during 
inflammatory reactions. We therefore suspected that there is 
another rapid thrombopoietic mode, in addition to PPF.
Although TPO has been identified as the most important 
regulator of platelet production (de Sauvage et al., 1994; Kuter, 
2007), it was recently reported that MK maturation and platelet 
biogenesis can occur independently of TPO (Ng et al., 2014). 
Intravital visualization of thrombopoiesis revealed that formation of proplatelets, which are cytoplasmic pro-trusions in bone marrow megakaryocytes (MKs), is domi-
nant in the steady state. However, it was unclear whether 
this is the only path to platelet biogenesis. We have identi-
fied an alternative MK rupture, which entails rapid cyto-
plasmic fragmentation and release of much larger numbers 
of platelets, primarily into blood vessels, which is morpho-
logically and temporally different than typical FasL-induced 
apoptosis. Serum levels of the inflammatory cytokine IL-1 
were acutely elevated after platelet loss or administration of 
an inflammatory stimulus to mice, whereas the MK-regulator 
thrombopoietin (TPO) was not elevated. Moreover, IL-1 
administration rapidly induced MK rupture–dependent 
thrombopoiesis and increased platelet counts. IL-1–IL-1R1 
signaling activated caspase-3, which reduced plasma 
membrane stability and appeared to inhibit regulated tu-
bulin expression and proplatelet formation, and ultimately 
led to MK rupture. Collectively, it appears the balance 
between TPO and IL-1 determines the MK cellular pro-
gramming for thrombopoiesis in response to acute and 
chronic platelet needs.
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Figure 1. Proplatelet formation is the dominant mode of thrombopoiesis, but there is an alternative megakaryocyte rupture mode, which produces much 
larger numbers of platelet-like particles. (A–G) Time-lapse images of thrombopoiesis in living BM from 6-wk-old CAG-eGFP (green) mice under steady-
state conditions (A, B, F, and G) or after treatment with TPO (C; 10 µg for 5 d; A, Video 1; B, Video 2; C, Video 3; F, Videos 4 and 5; and G, Video 6). 
Injected fluorescent dextran (red) shows the blood flow, and Hoechst (blue) labeled the nucleus. Slice views (top in A, C, and G), voxel views (bottom in 
B and F), and surface views (bottom row in A, B, C, and G) show MK surfaces and particle release at the single-platelet (triangle) level. (D and E) Numbers 
of particles released from MKs with proplatelet formation and MK rupture thrombopoiesis, which were calculated from visuals by automatic software. n = 50 
cells from 5 animals in each group. Note that MK rupture thrombopoiesis is rapid and associated with much greater numbers of released particles. 
(H) Automatic software analysis of thrombopoiesis mode. Calculated changes in MK perimeters and cytoplasmic GFP signal intensities are shown. The 
long arm projections (>50% of the length of the mean MK diameter) were identified as proplatelets and divided into short (<100 µm) and long (>100 µm) 
proplatelet formation. Increases in the perimeter (deformity) and decreases in GFP intensity (during rupture) were identified as the MK rupture pattern. 
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were still small (Fig. 1, C and D), which prompted us to search 
for alternative modes of thrombopoiesis.
MK rupture, the alternative mode of 
thrombopoiesis, can release large numbers 
of platelets over a short period
Rigorous 3D and high-speed examinations and surface visual-
ization revealed that there is another, minor, but distinct, mode 
of thrombopoiesis, which we named “MK rupture” thrombo-
poiesis (Fig. 1, D–G). During the rupture phenomenon, MKs 
exhibited ruffling and then irregular changes in cell shape, and 
GFP+ platelet-like particles were released from the cytoplasm 
primarily into BM vessel lumens (Fig. 1, F and G; and Videos 4–6). 
Thereafter, MKs showed a marked loss of the GFP signal from 
the cytoplasm along with an increase in the dextran signal. 
When we profiled the visuals of the thrombopoiesis process in 
MKs using automatic, software-based algorithms, we found 
that short PPF was the dominant mode of platelet biogenesis in 
the steady state (Fig. 1, H and I), but that MK rupture thrombo-
poiesis also occurred with increased particle number per a sin-
gle MK (Fig. 1 D). Moreover, the MK rupture thrombopoiesis 
was distinct from typical FasL-induced apoptosis, which had 
a much longer time course and was associated with blebbing, 
large protrusions, and gradual GFP loss (Fig. 1, J and K).
MK rupture increases in response  
to acute platelet needs
We also found that MK rupture–dependent platelet formation 
increased after intraperitoneal administration of anti-CD42b 
blocking antibody, which induces acute platelet loss, or thiogly-
colate, which induces innate inflammation (Fig. 2, A–C; and 
Video 7). This suggests that the MK rupture phenomenon medi-
ates rapid platelet release in response to acute platelet demand.
IL-1 contributes to MK rupture 
thrombopoiesis in response to acute 
platelet need
To determine whether TPO is involved in MK rupture thrombo-
poiesis, or whether other intrinsic factors are involved, we next 
sought mediators in BM cell culture medium that positively 
influenced MK production in the presence of TPO. Using this 
screening assay, we identified seven candidate factors and de-
termined that IL-1 increases platelet production from MKs to 
an even greater degree than TPO (Fig. 3, A and B). Moreover, 
serum IL-1 levels were acutely increased during platelet re-
covery after depletion using an anti-CD42b antibody, whereas 
increases in TPO levels were not seen until day 7 (Fig. 3 C). 
Increases in serum IL-1 levels induced in response to acute 
peritoneal inflammation evoked by thioglycolate injection were 
accompanied by transient increases in platelets (Fig. 3 D). 
In addition, neutralizing anti–IL-1 receptor (IL-1R) antibody 
However, no suggestions as to the detailed mechanism by which 
platelets are generated from MKs in the absence of TPO were 
provided. In addition, recent studies indicate that hematopoietic 
stem cells (HSCs) and MKs are in very close proximity within 
the hematopoiesis hierarchy, and that MKs and platelets can 
emerge directly from HSCs under stress conditions, e.g., after BM 
suppression by irradiation (Sanjuan-Pla et al., 2013; Yamamoto 
et al., 2013; Nakamura-Ishizu et al., 2014). Thus, the actual 
pathways of platelet biogenesis are not clear, and elucidation 
of unidentified thrombopoietic mechanisms, particularly under 
stressful conditions such as inflammation or acute thrombocy-
topenia, require direct visualization of the BM. We therefore 
endeavored to improve the capability of the two-photon micros-
copy technique such that we would be able to visualize platelet 
biogenesis from MKs at the single-platelet level and to trace the 
translocation of platelets into the blood circulation of the BM in 
living mice. Ultimately, we identified an alternative pathway 
entailing MK rupture–enhanced platelet release, which responded 
to acute platelet needs under regulation by IL-1. Our results 
shed light on what appears to be a novel mode of platelet release 
from BM MKs.
Results
Proplatelet type thrombopoiesis 
continuously regulates the platelet supply 
but provides limited numbers of platelets 
from mature MKs
To address the mechanism by which rapid platelet turnover 
is regulated, especially under stress conditions, we visualized 
megakaryopoiesis and dynamic thrombopoiesis in three dimen-
sions (3D) using an improved intravital visualization technique 
and focusing on BM MKs. The combined technologies of mul-
ticolor high-sensitivity GaAs detectors, resonance mirror high-
speed scanners, and a piezo-drive electronically controlled 
stage were applied to CAG-eGFP and CD41-tandem(td)Tomato 
mice, enabling us to monitor the behavior of single platelets 
shed from BM MKs (Fig. 1, A–C; Fig. S1; and Videos 1–3). 
MKs identified based on their large size, multinucleation, CD41 
positivity, and strong GFP signals in CAG-eGFP mice were 
mainly located in the border area between BM vessel lumens 
and the stroma.
With no intervention under steady-state conditions, fila-
mentous (elongated) proplatelets released small platelet-like 
particles from the tips of the protrusions within vessels (Fig. 1, 
A and B). The entire time course of this process was usually 
longer than the observation periods (1 h), during which release 
was intermittent, and the number of released particles was only 
1.4 ± 0.3 per minute from a single MK. TPO administration in-
creased PPF with development of longer (>100 µm) arm projec-
tions, but the numbers of released platelets (2.6 ± 0.5 per minute) 
The data shown are from a single representative experiment from among more than five cells from different animals. (I) MK dynamics in 6-wk-old CAG-eGFP 
mice. Short type proplatelet was dominant in the steady state. n = 50 HPFs from 5 animals in each group. *, P < 0.05 versus control mice. (J) Time-lapse 
images of FasL-induced apoptosis (5 µg/mouse, i.v.). Note that the entire time course was relatively slow, and was not associated with particle release. 
(K) Time duration of the MK rupture and proplatelet processes. The onset is defined as the increase in perimeter (irregularity), and the end as the loss of GFP 
intensity (cell death). n = 15 MKs from steady-state (for MK rupture) and FasL-treated mice (for apoptosis). Bars: (red) 20 µm; (blue) 5 µm.
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IL-1–dependent platelets were larger in size than those in 
TPO-treated mice (Fig. 4, J and K), and anti-CD42b antibody 
increased the large platelet populations in control mice but not 
in IL-1R1/ mice (Fig. S2). IL-1–dependent platelets also 
had shorter lifetimes, which was not affected by clodronate- 
mediated macrophage suppression (Fig. 4 L), confirming the 
intrinsic nature of the lifetime. The particles released in vivo 
stained positively with mitochondrial membrane potential dyes, 
indicating intact mitochondrial function (Fig. S3 A). Platelets 
isolated from IL-1–treated mice showed less JONA binding, 
but overall platelet aggregation in vitro and thrombus formation 
in vivo were comparable to the TPO-mediated responses. Thus, 
IL-1 stimulation leads to production of larger platelets with 
minor impairment but intact thrombotic function (Fig. S3).
IL-1-induces MK differentiation, 
maturation, and MK rupture–dependent 
platelet biogenesis with PPF inhibition  
in vitro
IL-1–induced MK rupture thrombopoiesis was also observed 
in fetal liver MKs, which enabled us to examine its molecular 
mechanism and to clarify differences from FasL-induced apop-
tosis (Fig. 5, A–D). As mentioned, the particles released from 
IL-1–treated MKs were larger than those induced by TPO 
(Fig. 5 E). IL-1 increased the ploidy and number of MKs (Fig. 5, 
F and G), as well as the release of platelet-sized CD41+CD42b+ 
particles (Fig. 5 H), indicating positive effects of IL-1 on MK 
differentiation, maturation, and platelet biogenesis, i.e., IL-1 
increased MK rupture thrombopoiesis.
diminished the platelet response by half and suppressed MK 
rupture (Fig. 3 E). These results indicate a direct contribution of 
IL-1 to acute thrombopoietic responses in MKs.
IL-1 induced MK rupture thrombopoiesis 
in BM MKs
When we further analyzed the effect of exogenous IL-1 on 
BM MK dynamics in vivo, we found that it markedly increased 
MK rupture but significantly decreased PPF without changing 
serum TPO levels (Fig. 4, A–D; Fig. S2; and Videos 8–10). 
Software analysis showed that the released particle number 
was 41.5 ± 6.3 per min from each ruptured MK, which is 
20 times higher than that achieved with PPF (Fig. 1 D). Circu-
lating platelet counts rapidly increased from day 1 onward, 
with transient reduction and following increase in MK num-
bers, but the effects of TPO on platelet counts were only seen 
at later times (Fig. 4, E–G). Conversely, platelet counts were 
reduced by a neutralizing anti–IL-1 or anti–IL-1R antibody. 
This action of IL-1 promoting MK rupture thrombopoiesis 
was dependent on the IL-1–IL-1R1 signaling axis, which was 
confirmed using IL-1/ CAG-eGFP and IL-1R1/ CAG-
eGFP mice (Fig. 4 H and Fig. S2), as well as in BM transplan-
tation experiments (Fig. 4 I).
Platelets released from IL-1–treated MKs 
are larger in size but show normal function
Using thiazole orange staining to detect reticulated platelets, we 
were able to distinguish platelets newly produced in IL-1–
treated mice from older conventionally produced platelets. The 
Figure 2. MK rupture thrombopoiesis responds to acute platelet needs. (A) Time-lapse image of MK rupture mode thrombopoiesis in MKs in 6-wk-old 
CAG-eGFP mice after administration of a neutralizing anti-CD42b antibody (100 µg/mouse i.p. daily for 3 d; Video 7). (B and C) Platelet counts and MK 
dynamics in 6-wk-old CAG-eGFP mice treated with anti-CD42b antibody (B) or with thioglycolate, which induces acute peritoneal inflammation (C). n = 8 
animals in each group. Bars: (red) 20 µm; (blue) 5 µm. *, P < 0.05 versus day 0.
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the effect of IL-1 on platelet counts in vivo (Fig. 6 K) and 
platelet-like particle releases in vitro (Fig. 5 H). Indeed, IL-1–
induced MK rupture thrombopoiesis was blocked in Casp-3/ 
mice but not Thpo/ mice (Fig. 6 L). These results indicate the 
rupture machinery is associated with caspase-3 activation via 
IL-1/IL-1R1 but is distinct from TPO-dependent signaling 
and typical apoptosis.
IL-1–treated MKs show impairment  
of proportional microtubule assembly
We next asked how IL-1–IL-1R1 signaling with preapop-
totic gene activation changes the mode of platelet generation 
from PPF to rupture (Fig. 7). It was previously shown that 
PPF-mediated platelet generation is microtubule dependent 
(Patel et al., 2005; Thon and Italiano, 2010; Kunishima et al., 
2014; Machlus et al., 2014). To determine whether IL-1 in-
fluences microtubule dependency, two microtubule inhibitors 
(colchicine or paclitaxel), were administered to mice or fetal 
liver MKs with or without subsequent IL-1 treatment, after 
IL-1 stimulation induces caspase-3 
activation without evident apoptosis
RT-PCR analysis of cultured fetal liver MKs showed that IL-1 
increased expression of Gata1, Bak1, and Bax, which are known 
to be involved in thrombopoiesis and preapoptotic gene activa-
tion (Fig. 6 A; Kaushansky, 2003). Although there has been 
controversy regarding the caspase cascade in thrombopoiesis 
(De Botton et al., 2002; Clarke et al., 2003; Josefsson et al., 
2014), IL-1 induced caspase-3 as well as p53 activation and 
AKT/ERK phosphorylation via IL-1R1 (Fig. 6, B–D; and Fig. S4). 
siRNA-mediated knockdown of IL-1R1 efficiently suppressed 
the pAKT–pERK signal (Fig. 6 C and Fig. S4), but Thpo and 
Il1r1 expression in fetal liver MKs and TPO-R expression in 
isolated platelets were unaltered by IL-1 (Fig. 6, E and F). Im-
munofluorescence experiments also revealed the activation of 
caspase-3 and release of von Willebrand factor–positive gran-
ules, but TUNEL staining was negative, which makes this pro-
cess different from typical FasL-induced apoptosis (Fig. 6, 
G–J). Caspase inhibition using Z-VAD (OMe)-FMK suppressed 
Figure 3. IL-1 levels increase with acute platelet demands. (A) Initial screening for thrombopoietic humoral factors in cultured BM cells. BM cells isolated 
from 6-wk-old WT mice were cultured without (CTRL) or with TPO (50 ng/ml) plus stem cell factor (SCF; 50 ng/ml). After culture for 7 d, secretion of humoral 
factors into the culture medium was assessed using MAPs analysis. Shown are the MAPs value ratios (TPO+SCF/CTRL). Seven factors with a ratio of >2.5 
were identified. LT, lymphotactin; GCP, granulocyte chemotactic protein. n = 5 experiments. (B) BM cells were collected and then cultured in the presence 
of IL-1, IL-1, IL-2, IL-3, IL-6, LT, IL-12 subunit p70, or GCP-2. Production of CD41+CD42b+ particles was evaluated in the culture media after 7-d culture. 
The percent value was normalized to that of medium from vehicle-treated cells. n = 5 experiments. (C and D) Platelet counts, MPV values, and serum IL-1, 
IL-1, IL-6, and TPO levels after administration of anti-CD42b antibody (R300) (C) or thioglycolate (D). n = 5–8 animals in each group. (E) MK dynamics 
and platelet counts after thioglycolate-induced peritoneal inflammation in 6-wk-old CAG-eGFP mice, which were simultaneously treated with IgG or neutral-
izing anti–IL-1R antibody (100 µg/mouse.). n = 8 animals in each group. *, P < 0.05 versus CTRL group.
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Figure 4. IL-1-induced MK rupture yields larger platelets. (A–C) Time-lapse images of thrombopoiesis in living BM from 6-wk-old CAG-eGFP mice treated 
with IL-1 (10 µg/mouse s.c. daily for 5 d). (A, Video 8; B, Video 9; and C, Video 10.) (D) Quantification of MK dynamics and numbers and platelet counts 
in 6-wk-old CAG eGFP mice treated with TPO (10 µg/mouse s.c. daily for 5 d [TPO10], or with 70 µg/mouse daily for 3 d [TPO70]) or IL-1 (10 µg/mouse 
s.c. daily for 5 d). The BM was visualized and platelet counts were analyzed 7 d after the first administration. n = 50 high-power fields from 5 animals for 
each group. *, P < 0.05 versus vehicle treated mice. (E and F) Platelet counts in isolated blood (E) and the CD41+CD42b+ MK fraction among Lin BM 
cells (F) treated with vehicle (CTRL), low-, or high-dose TPO, IL-1, anti–IL-1 neutralizing antibody (IL-1Ab), anti–IL-1R neutralizing antibody (IL-1RAb), or 
isotype-matched control antibody (IgG1 for IL-1Ab, IgG2 for IL-1RAb). All antibodies were used at 100 µg/mouse administered i.p. daily for 3 d. n = 8 
animals in each group. (G) Identification of newly produced MKs using MX-Cre-GFP mice. GFP-labeled cells were analyzed among LinCD41+CD42b+ BM 
cells 2 d after PIPC injection. The data shown are from a single representative experiment from among three repeats. (H) Quantification of thrombopoiesis 
under physiological conditions in 6-wk-old IL-1+/+, IL-1 /, IL-R1+/+, and IL-1R1/ mice. (I) MK dynamics in chimeric mice. n = 50 high-power fields from 
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Tuba1c, or Tuba4a expression (Fig. 7 E and not depicted). We 
found the formation of a demarcation membrane system and 
development of platelet territories in IL-1–treated MKs be-
fore membrane rupture (Fig. 7 F and Fig. S5). Platelets from 
Thpo/ mice treated with IL-1 showed an absence of proper 
tubulin distribution, suggesting 1-tubulin oversupply, and 
those from IL-1–treated WT mice are mostly spheroid shape 
rather than elongated shape by WT or TPO-treated platelets 
(Fig. 7, G–I; and Fig. S5). We concluded that IL-1–induced 
disorganization of microtubule assembly accounts for the dys-
regulated - and 1-tubulin synthesis, which should contrib-
ute to the PPF inhibition and MK rupture as a result.
which we examined whether the dynamics of platelet-like par-
ticle formation and release were suppressed by either drug in 
the presence of IL-1 (Fig. 7, A and B). Examination of tubu-
lin immunofluorescence in fetal liver–derived MKs showed 
that IL-1 promoted formation of small vesicles in the periph-
ery of MKs that all stained positive for 1-tubulin, but some 
were negative for -tubulin (Fig. 7, C and D). However, TPO 
accelerated PPF, with the well-coordinated distribution of 
- and 1-tubulin within MKs. TPO also similarly increased ex-
pression of both Tuba1a and Tubb1. In contrast, IL-1 induced 
a 10-fold increase in Tubb1 expression, and a 50-fold increase 
when combined with TPO, while having no effect on Tuba1a, 
5 animals in each group. *, P < 0.05 versus control mice. (J) Fractions of thiazole orangehigh platelets in isolated blood from WT mice treated with vehicle, 
TPO, IL-1 and/or clodronate. n = 5 mice. (K) Flow cytometric size analysis of thiazole orangehigh and thiazole orangelow platelets in WT mice treated with 
TPO or IL-1. (L) Platelet lifetimes in WT mice treated with vehicle, low-dose TPO, IL-1, and/or clodronate. Platelets were labeled in vivo with anti-CD42c 
antibody (X488). During the gradual disappearance of circulating X488+ platelets, we were able to distinguish newly generated platelets from previously 
circulating ones based on their X488 negativity. n = 5 mice. Bars, (red) 20 µm. *, P < 0.05.
 
Figure 5. IL-1–induced MK differentiation and rupture-dependent platelet biogenesis in vitro. (A–C) Time-lapse images of cultured MKs. Liver cells were 
collected from fetal CAG-eGFP mice on embryonic day 13 and cultured with TPO. On day 7 of culture, the cells were washed and incubated with anti-
CD41 and Hoechst 33342. MKs were identified in the cultures as multinucleate and staining positive for CD41. MKs were then treated with TPO, IL-1, or 
TPO plus Fas ligand 1 h before the experiments. Proplatelet production was observed in the presence of TPO, whereas MK rupture was seen in the pres-
ence of IL-1. (D and E) Quantification of MK dynamics (D) and released particle size (E). n = 20 low-power fields (D) and n = 20 particles (E). Some cells 
were cultured with Z-VAD (OMe)-FMK (100 µM) 1 d before the experiments. (F) Fetal liver cells were isolated and cultured with TPO for 6 d. Differentiated 
MKs were washed and then incubated for 1 d with TPO, IL-1, and anti–IL-1 neutralizing antibody. Ploidy was analyzed in CD41+CD42b+Lin MKs. The 
data shown are from a single representative experiment from among three repeats. (G and H) BM cells isolated from 6-wk-old WT mice were cultured, 
and CD41+CD42b+Lin MKs were counted (G) in each well after 7 d. The percent value was normalized to that of a control well. n = 5 experiments. 
(H) Release of CD41+CD42b+ particles into the culture medium. n = 5 experiments. *, P < 0.05.
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Figure 6. IL-1–induced atypical apoptosis with caspase-3 activation in fetal liver MKs. (A and B) Liver cells were obtained from fetal WT mice on 
embryonic day 13, cultured with TPO or IL-1, and analyzed on day 7. (A) RT-PCR analysis of gene expression in the harvested cells. The values were 
normalized to a vehicle-treated control. n = 5 experiments. (B) Flow cytometric analysis of caspase-3 activation in LinCD41+CD42b+ MKs. (C) Fetal liver 
cells were cultured with TPO. siRNA-mediated knockdown was performed on day 4. On day 7, cells were washed, incubated with TPO, IL-1, or IL-1 
for an additional 1 d, and pAKT–pERK signaling in LinCD41+CD42b+ MKs was analyzed on day 8. The data shown are from a single representative 
experiment from among three repeats (B and C). (D) Western blotting of p53 and phospho-p53 in fetal liver cells cultured with TPO and IL-1 from day 0 
to 7. MKs were enriched with discontinuous albumin density gradient centrifugation. (E) Fetal liver cells were differentiated using TPO for 7 d, and then 
stimulated with vehicle, TPO, IL-1, or IL-1 for an additional 1 d, after which gene expression was analyzed using RT-PCR. (F) Flow cytometric analysis of 
T. orangehigh and T. orangelow platelets isolated from WT mice treated with TPO or IL-1. NC denotes a negative control. The data shown are from a single 
representative experiment from among five repeats. (G–J) Immunofluorescence analysis of fetal liver MKs, which were cultured and differentiated from 
day 0 to 7 with TPO or IL-1. Some cells were treated with Fas-ligand from day 6 to 7 after differentiation with TPO (FasL). Note that IL-1–treated MKs were 
caspase-3–positive with release of von Willebrand factor–positive granules, but TUNEL staining was negative, which was different than typical FasL-induced 
apoptosis with blebbing. (K) Blood cell counts in WT mice treated with TPO, IL-1, and/or Z-VAD (OMe)-FMK. (L) MK dynamics and platelet counts in WT, 
Casp3/, and Thpo/ mice treated with vehicle or IL-1. n = 3–8 mice. Bars, (red) 20 µm. *, P < 0.05 versus CTRL group.
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Figure 7. IL-1 inhibited regulated tubulin assembly and proplatelet formation. (A) Quantification of MK numbers and dynamics and platelet counts in 
6-wk-old CAG-eGFP mice treated with IL-1 (10 µg for 5 d), colchicine (5 mg/kg i.v. once 6 h before experiments), and/or paclitaxel (10 mg/kg i.v. once 
6 h before experiments). The BM was visualized and platelet counts were analyzed 7 d after the first administration. n = 24 high-power fields from 8 animals 
in each group. *, P < 0.05 versus control (WT) (B–D) Immunofluorescence analysis of fetal liver MKs cultured and differentiated from day 0 to 7 with TPO 
or IL-1. In addition, the cells were treated with colchicine (2.5 µM) or paclitaxel (2.5 µM) from day 6 to day 7 (B). Some cells were also treated with Fas-
ligand with TPO from day 6 to 7 (FasL). On day 7, the cells were fixed and stained (C and D). (E) RT-PCR analysis of gene expression in harvested cells. 
The values were normalized to vehicle-treated control. n = 8 experiments. (F) Electron microscopy of isolated BM MKs from TPO or IL-1 mice. Note that 
demarcation membrane system was similarly developed in two mice (1 and 2), before rupture, and fragments indicated several platelets (3 and 4). Bars, 
2 µm. (G) Immunofluorescence study of tubulin distribution in platelets from WT, Thpo/ mice, or Thpo/ mice treated with IL-1. (H) Electron microscopy 
of isolated platelets from WT mice treated with vehicle (WT), TPO, or IL-1. (I) The short and long axis length was measured in randomly selected individual 
platelets, and ratio (short/long) was evaluated in 40 cells for each groups. Bars, 2 µm. *, P < 0.05.
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et al., 2007; Takayama et al., 2010). However, although recent 
in vivo imaging-based analyses confirmed the presence of PPF 
(Junt et al., 2007; Zhang et al., 2012), we found that the number 
of platelets produced from each MK was both consistent with 
previously reported numbers (Thon et al., 2012; Avanzi and 
Mitchell, 2014) and too low for an adequate response to acute 
platelet needs or inflammatory stimuli.
Herein we demonstrated an alternative MK rupture–type 
thrombopoietic process, which can provide 20 times more 
platelets than PPF, released primarily into BM vessels within 
1 h (Fig. 1 D), and which we visualized for the first time using 
high-speed two-photon microscopy with multicolor high-sensi-
tive GaAs detectors (Fig. 1). The novel MK rupture–dependent 
pathway is primarily regulated by the inflammatory cytokine 
IL-1, and is morphologically and mechanically distinct from 
PPF and typical FasL-induced apoptosis, as well as from the re-
cently reported cytoplasmic elongation of large platelet progen-
itor structures (Thon and Italiano, 2010; Kowata et al., 2014), as 
summarized in Table S1 and Fig. 9.
Ng et al. (2014) recently reported that MK maturation and 
final platelet shedding can both be independent of TPO signal-
ing, but they did not address alternatives to TPO. In this study, 
we found that IL-1–IL1R1 signaling positively influences the 
MK differentiation phase, as well as platelet shedding through 
rupture, which compensated for the deficiency of TPO signal-
ing in MKs (Ng et al., 2014). In addition, a shear-dependent 
IL-1 induces mechanically and functionally 
weaker plasma membrane structure
The multiple functional changes seen in IL-1–treated MKs be-
fore membrane rupture during thrombopoiesis were also exam-
ined. Using atomic force microscopy to evaluate MKs’ ability 
to push a bead-attached cantilever or exert contractile force to 
pull up a cantilever, it was found that IL-1–treated MKs were 
less stiff and thus exerted less force (Fig. 8, A and B). Fluor-
escent recovery after photobleaching (FRAP) analysis further 
confirmed that membrane stability was reduced in IL-1–treated 
mature polyploid MKs, but not in mononuclear CD41+ cells 
(immature MKs), and that it was restored by caspase inhibi-
tion (Z-VAD [OMe]-FMK; Fig. 8, C and D; Ahn et al., 2002). 
These results strongly indicate that IL-1 reduces plasma mem-
brane potential, which leads to a mechanically and functionally 
weaker membrane structure and drives MKs toward MK rup-
ture thrombopoiesis.
Discussion
Novel MK rupture thrombopoiesis
In vitro platelet biogenesis from fetal liver MKs, human CD34+ 
cells, embryonic stem cells, or induced pluripotent stem cells all 
consistently show the presence of PPF and release of fragments 
from the tips of elongated pseudopodal structures under steady-
state and TPO-stimulated conditions (Italiano et al., 1999; Eto 
Figure 8. IL-1 drives MK rupture thrombopoiesis by reducing functional and mechanical membrane stability in MKs. (A and B) Fetal liver cells from WT 
mice were cultured for 7 d with IL-1 or TPO, after which MKs were evaluated using atomic force microscopy by pushing a bead-headed cantilever to 
measure stiffness (A) and pulling up on a membrane-attached cantilever to measure contractile force (B). Representative force-measurement curve, stiffness, 
and contractile force against cantilevers were shown. n = 20 measurements. (C and D) Fluorescence recovery after photobleaching (FRAP) analysis. Fetal 
liver MKs were cultured for 7 d with IL-1 or TPO. Some cells cultured with TPO were also treated with Z-VAD (OMe)-FMK (100 µM) 1 d before the experi-
ments. MKs were stained with Di8-ANEPPS and then photobleached in a region of interest (ROI; red box). Restoration of Di8-ANEPPS intensity reflected 
membrane fluidity and instability. The left panels show representative snapshots during photobleaching and the corresponding Di8-ANEPPS signals. MKs 
were divided into mature highly segmented (more than two nuclear segmentations) and not segmented (one or two nuclear segmentations) groups. n = 20 
examinations from 5 specimens. *, P < 0.05 versus TPO.
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may also be associated with platelet shape in generation. 
Platelets by IL-1 appeared to display more spheroid but 
PPF-dependent platelets were longitudinal (Fig. 7, G–I; and 
Fig. S5), as demonstrated previously (Thon and Italiano, 
2010). Interestingly, this membrane instability was depen-
dent on caspase activity in only mature MKs (Fig. 8 D). That 
the action of IL-1 in MK rupture thrombopoiesis was cas-
pase-3 dependent (Fig. 6, K and L) suggests caspase activa-
tion may occur downstream of the IL-1–ILR1 axis in 
association with alteration of the cell membrane structure. 
The caspase-dependent thrombopoiesis theory has been dis-
cussed for a long time (De Botton et al., 2002; Clarke et al., 
2003; Josefsson et al., 2014). Our data provide evidence of 
caspase dependency in platelet biogenesis; however, the cas-
pase involvement is independent of TPO-mediated PPF, as 
recently demonstrated (Josefsson et al., 2014). But the de-
tailed mechanism of caspase activation or p53 up-regulation 
in MK rupture thrombopoiesis must be elucidated further.
In conclusion, our findings provide direct evidence that 
IL-1 is an acute platelet releasing factor that induces enhanced 
platelet release through rupture of the mature MK membrane. 
This novel mechanism may enable rapid restoration in platelet 
numbers, but with insufficient microtubule organization. It ap-
pears the balance between TPO and IL-1 determines the cellu-
lar programming of MKs for thrombopoiesis in response to 
acute and chronic platelet needs.
mechanism may also promote TPO-independent platelet gener-
ation (Jiang et al., 2014).
MKs respond to acute platelet demand  
via IL-1
Under acute inflammatory or cytopenic conditions, rapid elevation 
of IL-1 promoted a change in cell programing to MK rupture 
thrombopoiesis (Fig. 2 and 3). Reductions in platelet counts during 
acute inflammation induced by neutralizing anti–IL-1 antibody 
indicate that an urgent requirement for platelet recruitment or 
recovery as a host defense may be associated with inflammation-
mediated elevation of IL-1 levels, as reported previously (Rider 
et al., 2011). However, serum levels of multiple inflammatory cy-
tokines, including IL-1, IL-2, IL-6, and IL-11, were also elevated 
and may contribute to the increase in platelet production (Fig. 3). 
Although IL-1, produced from platelets during acute inflamma-
tion, reportedly stimulates MK polyploidization (Yang et al., 2000; 
Denis et al., 2005; Beaulieu et al., 2014), the levels of IL-1 were 
not associated with elevation of platelets after administration of 
anti-CD42b antibody (Fig. 3 C). This result is consistent with the 
fact that the phenotypes of IL-1 and IL-1 knockout mice differ 
from one another (Nambu et al., 2006).
IL-1–treated MKs showed clear changes to their cell 
membrane before MK rupture (Fig. 8). The plasma membrane 
was functionally and mechanically less stable in IL-1–treated 
MKs. Instability of membrane structure after IL-1 treatment 
Figure 9. Schematic model of the two modes of throm-
bopoiesis. (A) Morphological features of BM MKs with 
proplatelet formation and MK rupture type thrombopoiesis. 
(B) Dysregulation of tubulin expression and instability of 
plasma membrane of MK with rupture. 
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using an automatic algorithm in NIS-Elements (Nikon) and custom designed 
software (IMAGICA Imageworks). Slice, voxel, and maximum intensity pro-
jection views are provided in the figures and videos. Also calculated by the 
software were the particle release, time-dependent changes in MK perime-
ters, and the cytoplasmic GFP signal. After measuring the proplatelet long 
axis, a >50% increase in perimeter (deformity) and a decrease in the cyto-
plasmic GFP signal intensity (rupture) were identified as the rupture pattern. 
Alternatively, MKs showing long arm projections (>50% of the length of the 
average cell diameter) were deemed to contain proplatelets, and we catego-
rized long (>100 µm) and short (<100 µm) proplatelet formation based on 
the arm length. The total numbers of rupture-type and proplatelet-type MKs 
detected during the observation periods were counted.
Fetal liver cell cultures
Liver cells were collected from fetal WT mice on embryonic day (E) 13. Single-
cell suspensions, prepared through successive passaging, were cultured in 
DMEM supplemented with 10% FCS without (CTRL) or with TPO (50 ng/ml), 
SCF (50 ng/ml), Fas ligand (1 µg/ml), and/or IL-1 (50 ng/ml). On day 7 
of culture, the cells were washed and analyzed. MKs were enriched by 
discontinuous albumin density gradient centrifugation before analysis. Cas-
pase activation was evaluated using NucView Caspase-3 (Biotium; Bosch 
and Franklin-Tong, 2007). The mechanical properties of cultured fetal liver 
MKs were evaluated using atomic force microscopy (Nanowizard JPK In-
struments AG) with bead-attached or sharp-head cantilevers.
For time-lapse imaging, some cells were washed and incubated 
with RPE-conjugated rat anti-CD41 (MWReg30) and Hoechst 33342. 
Differentiated MKs, identified as multinucleate and staining positively 
for CD41, were visualized at 37°C in DMEM using a confocal micro-
scope (Nikon A1R) with a 100× (N.A. 1.25) oil immersion objective 
lens (Nikon).
FRAP analysis
To evaluate plasma membrane stability, we performed FRAP analysis with 
cultured fetal liver MKs. The MKs were stained with Di8-ANEPPS (5 µM), 
after which selected regions of interest (ROIs) were photobleached for 30 s. 
After photobleaching, Di8-ANPPES intensities within ROI lesions were con-
tinuously recorded using a single-photon confocal microscope (Nikon-A1R). 
The spontaneous recovery of the ROI signals was evaluated as an index of 
membrane stability/fragility, as previously reported (Ahn et al., 2002).
Immunofluorescence study
For immunofluorescence analyses, the cells were fixed in 4% paraformal-
dehyde for 45 min and permeabilized with 1% Triton X-100 (EMD Milli-
pore) for 10 min. Thereafter, the specimens were blocked and incubated 
first for 12 h with a primary antibody (rabbit anti–1-tubulin [Patel-Hett 
et al., 2008], rat anti-CD41 [MWReg30; BioLegend], rabbit anti-von Wille-
brand factor [Emfret], or rabbit anti-active caspase-3 [Millipore]. They 
were then incubated for 1 h with an RPE-conjugated rat anti-CD41 
(MWReg30), Alexa Fluor–conjugated mouse anti–-tubulin (Invitrogen) 
and/or goat secondary antibody (Invitrogen). Finally, the cells were coun-
terstained for 1 h with Hoechst 33342, and images were captured using a 
confocal microscope (Nikon A1R). The cells were excited using three laser 
lines (405 nm, 488 nm, and 561 nm), and the emission was collected 
using appropriate narrow band-pass filters and GaAs detectors.
Electron microscopy
For electron microscopy, MKs were fixed in a mixture of 0.5% glutaralde-
hyde and 2% paraformaldehyde, washed, and post-fixed with 1% osmium 
tetroxide. After dehydration, the collected pellets were embedded in Epoxy 
resin. Ultrathin sections (60–80 nm thick) were then cut and stained with 
2% uranyl acetate and Reynolds’ lead citrate. Samples were observed in a 
transmission electron microscope (HT7700; Hitachi) operating at 80 kV.
Preparation of cells and flow cytometry
As previously described (Nishimura et al., 2009), we isolated BM cells 
from the scalp and femurs by flushing them with PBS, and collected blood 
samples from tail veins or by cardiac puncture under anesthesia. The cells 
were washed twice with PBS, incubated for 8.5 min in erythrocyte-lysing 
buffer, and finally suspended in PBS supplemented with 3% fetal bovine 
serum. The isolated cells were then incubated with FcBlock antibody (BD) 
for 15 min on ice, labeled with dye-conjugated antibodies, and analyzed 
by flow cytometry using a Canto II flow cytometer (BD), spectrum analyzer 
SP6800 (Sony), and FlowJo 7.2.2. software (Tomy Digital Biology). Pro-
pidium iodide (Invitrogen) or a Zombie NIR kit (BioLegend) was used to ex-
clude dead cells. Conventional approaches, including Western blotting, 
Materials and methods
Mice
WT C57BL/6J, B6 and B6.129S7-Il1r1tm1Imx/J IL (IL-1R knockout) mice were 
obtained from Japan Charles River Laboratories. A null mutation in Il1r1 
was generated by homologous recombination using a replacement vector 
in which a 2.4-kb EcoR1–Pst1 fragment encompassing two exons was re-
placed with a PGKneo cassette. B6.Cg-Tg(Mx1-cre)1Cgn/J mice were gifts 
from the Institute of Physical and Chemical Research ([RIKEN] Saitama, Japan). 
The transgenes used were the mouse Mx1 gene promoter, nuclear localiza-
tion sequence-modified Cre recombinase and a fragment from the human 
growth hormone gene. B6.Cg-Tg(CAG-floxed Neo-EGFP)REP08Osb mice 
carrying the transgene for the CAG promoter and EGFP cDNA separated 
by a floxed neo cassette were a gift from Riken (Matsumura et al., 2004). 
IL-1/ mice were provided by Y. Iwakura (Tokyo University of Science, 
Tokyo, Japan; Horai et al., 1998). A null mutation in IL-1 was generated 
using a replacing vector in which a 1.5-kb DNA fragment between the 
Sau3AI and KpnI sites in exon 5 and intron 5, respectively, was replaced 
with a lacZ-pA-PGK-hph-pA cassette. B6N.129S1-Casp3tm1Flv/J (Casp-3/) 
mice were obtained from Japan Charles River Laboratories. A targeting 
vector was designed to replace the caspase protease-conserved catalytic 
site of the endogenous gene with a PGK-neo cassette. Thpo KO mice were 
generated using a targeting vector to remove exon 3 by inserting a neo 
cassette, and were provided by B. Heissig (The University of Tokyo, Tokyo, 
Japan; de Sauvage et al., 1996).
Animal models
To assess the contributions made by humoral factors, 5-wk-old CAG-eGFP 
mice were treated with TPO (Sigma-Aldrich) or IL-1 (R&D Systems or Bio-
Legend) at dosages of 10 µg/mouse subcutaneously (SC) daily for 5 d or 
70 µg/mouse SC daily for 3 d. The mice were visualized and examined at 
6-wk-old, 7 d after the first treatment. Some mice were also treated with 
neutralizing antibodies against IL-1 (R&D Systems or BioLegend), IL-1R 
(BioLegend), isotype-matched control antibody (BioLegend), or Fas Ligand 
(5 µg/mouse i.v.; R&D Systems). All antibodies were administered at 100 µg/
mouse i.p. daily for 3 d.
To assess the effect of acute inflammation, thioglycolate (Sigma- 
Aldrich) was administered i.p. (3 ml of 3% solution/mouse once). To exam-
ine the effect of caspase inhibition, mice were treated with the pan-caspase 
inhibitor Z-VAD (OMe)-FMK (3 mg/kg IP daily for 5 d; Merck Millipore). 
Clophosome (200 µl/mouse; FormuMax Scientific Inc.) was administered 
i.p. to deplete macrophages.
To obtain chimeric mice, 6-wk-old WT mice were lethally irradiated 
at a dose of 9.5 Gy, after which they were transplanted with BM total cells 
from age-matched IL-1R//CAG-eGFP, IL-1//CAG-eGFP, or control 
(IL-1R+/+/CAG-eGFP or IL-1+/+/CAG-eGFP) mice. 6 wk after transplanta-
tion, BM dynamics were scored.
Intravital microscopy for thrombopoiesis in living BM
To visualize MK dynamics in scalp BM, we used in vivo multiphoton micros-
copy, which is a modification of the single photon intravital visualization 
technique (Nishimura et al., 2008; Takizawa et al., 2010). CAG-eGFP 
and CD41-tdTomato mice were anesthetized by injection with urethane 
(1.5 g/kg), after which the scalp skin was removed, and the mice were se-
cured to the heated piezo-drive stage (Tokai Hit; Nikon) of an inverted mi-
croscope (Eclipse Ti; Nikon). Texas Red-dextran (25 mg/kg BW) and 
Hoechst 33342 (10 mg/kg) were injected to visualize cell dynamics and 
blood flow. Use of this approach for identification was validated through 
flow cytometric analysis of samples of scalp and femur BM and direct intra-
vital staining with an anti-CD41 antibody (Fig. S1). The tissue was excited 
at a wavelength of 920 nm using a Ti:sapphire laser (Vision II; Coherent), 
and images were captured as XYZ-T images using an A1R-MP system 
(Nikon); the X direction was scanned using a resonance mirror, the Y direc-
tion using a galvano mirror, and the Z direction using the piezo-drive 
stage. Because highly sensitive GaAs detectors were used, the laser power 
usually did not exceed 15% of the maximum for the Vision II laser. A 40× 
(N.A. 1.15) water immersion objective lens (Nikon) was used, and the im-
ages were captured at 1.5× zoom. The dwelling time for one pixel was 
0.1 µs. Z-stacks were usually 60 µm thick and composed of 1-µm slice 
images. We also avoided phototoxicity by first characterizing the effects of 
the laser and reactive oxygen scavengers.
Image analysis
In each experiment involving intravital visualization, >10 high-power field 
XYZ-T images were acquired. The collected data were analyzed and visualized 
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shows MK phenotype of IL-1 / and IL-1R1/ mice, and serum TPO 
levels after IL-1  treatment. Fig. S3 shows thrombus formation function of 
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induced platelets. Online supplemental material is available at http://www 
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